Should Californians give more money for stem cell research?
By Bradley J. Fikes,
San Diego Tribune [quotes Marcy Darnovsky]
| 04. 20. 2017
Are Californians getting their money’s worth for the $3 billion they invested in stem cell science in 2004? Is there cause for optimism that major breakthrough discoveries are about to happen? What is holding back stem cell treatments from reaching patients?
These are some of the issues to be addressed Thursday in San Diego at a special stem cell meeting that’s free and open to the public.
The session is sponsored by California’s stem cell agency and UC San Diego, a major hub of stem cell research and experimental treatment.
The event is the first in a statewide outreach tour by the California Institute for Regenerative Medicine, or CIRM.
The agency is projected to run out of money in 2020 unless more money is raised from public or private sources, and the series of forums is partly meant as a way to persuade voters to further support the institute with more funding.
PUBLIC FORUM:
The free event “Stem Cell Therapies and You” is slated for noon to 1:00 p.m. at the Sanford Consortium for Regenerative Medicine...
Related Articles
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...
By Nahlah Ayed, CBC Listen | 10.22.2025
Egg freezing is one of today’s fastest-growing reproductive technologies. It's seen as a kind of 'fertility insurance' for the future, but that doesn’t address today’s deeper feelings of uncertainty around parenthood, heterosexual relationships, and the reproductive path forward. In this...
By [cites CGS' Katie Hasson], KCBS Radio | 11.19.2025
This is Ask An Expert, where every weekday at 9:20am, KCBS Radio is giving you direct access to top experts in various fields. Today: Gene-editing technology allows scientists to work with DNA in unprecedented ways, but there are larger scientific...
By Antonio Regalado, MIT Technology Review | 10.31.2025
A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create genetically edited babies, marking the largest known investment into the taboo technology.
The new company, called Preventive, is...